# Ulsanic Tablet Uses in Pakistan
Ulsanic (Sucralfate 1g) is a commonly prescribed medicine in Pakistan. This guide covers all approved uses, indications, and essential information.
---
Ulsanic Ke Primary Uses
1. Peptic Ulcer Disease (Duodenal aur Gastric Ulcers)
Sucralfate is used in the treatment of duodenal and gastric ulcers. The acidic environment of the stomach polymerizes sucralfate, forming a thick protective gel over the ulcer crater. This gel keeps stomach acid, pepsin, and bile salts away from the ulcer surface — creating the right conditions for healing.
When to use: After diagnosis of peptic ulcer disease, as prescribed by your doctor.
---
2. GERD — Gastroesophageal Reflux Disease
In GERD, stomach acid flows back into the esophagus (foodpipe), causing burning sensation and discomfort in the chest. Sucralfate protects the esophageal lining from acid damage via a protective coating.
When to use: After GERD diagnosis, as directed by your doctor.
---
3. Gastritis — Stomach Lining Ki Sazan
In gastritis, the inner lining of the stomach becomes inflamed. Sucralfate provides a protective barrier over the inflamed lining and eases symptoms.
When to use: After gastritis is confirmed by your doctor.
---
Secondary Use
Stress Ulcer Prophylaxis: Sucralfate is used to prevent stress ulcers in critically ill patients in hospital (e.g., ICU patients, ventilated patients). This is done under doctor supervision.
---
Kise Lena Chahiye?
Ulsanic is suitable for patients who have been diagnosed by a doctor with peptic ulcer disease, GERD, or gastritis. Avoid self-medication — this is an Rx-only medicine.
---
Kab NA Lein
- If allergic to sucralfate or any of its ingredients
- In severe renal impairment — always discuss with your doctor
- When taken with antacids without a 30-minute gap
---
Summary
Ulsanic (Sucralfate 1g) is an effective gastric mucosal protectant used for peptic ulcer, GERD, gastritis, and stress ulcer prophylaxis as directed by your doctor. Always follow your doctor's prescription.
---
Compiled by the PakVita Editorial Team · AI-assisted drafting with editorial review · Sourced from DRAP, WHO, BNF · Last updated: 2026-06-17
Sources: [DRAP](https://www.dra.gov.pk/drap-databases/registered-drug-products/) · [WHO EML 2023](https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.02) · [BNF](https://bnf.nice.org.uk/)
---
> The information on this page is for awareness only. It is not medical advice. Always consult your doctor or pharmacist before taking any medicine. PakVita is not responsible for any harm.